Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
363 GBX | +0.97% | +1.11% | +3.57% |
Mar. 25 | Chemring Director Ord sells GBP500,000 in shares | AN |
Mar. 18 | Stocks downbeat before central bank rate storm | AN |
Sales 2024 * | 508M 641M | Sales 2025 * | 548M 691M | Capitalization | 989M 1.25B |
---|---|---|---|---|---|
Net income 2024 * | 53M 66.91M | Net income 2025 * | 58M 73.22M | EV / Sales 2024 * | 2.07 x |
Net Debt 2024 * | 63.7M 80.42M | Net Debt 2025 * | 68.83M 86.9M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
19.1
x | P/E ratio 2025 * |
17.4
x | Employees | 2,600 |
Yield 2024 * |
2.16% | Yield 2025 * |
2.38% | Free-Float | 98.21% |
Latest transcript on Chemring Group PLC
1 day | +0.97% | ||
1 week | +1.11% | ||
Current month | +4.61% | ||
1 month | +5.83% | ||
3 months | +3.12% | ||
6 months | +32.00% | ||
Current year | +3.57% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ord
CEO | Chief Executive Officer | 57 | 18-05-31 |
Director of Finance/CFO | 45 | Oct. 31 | |
Andrew Davies
BRD | Director/Board Member | 57 | 16-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sarah Ellard
BRD | Director/Board Member | 53 | 93-12-31 |
Laurie Bowen
BRD | Director/Board Member | 62 | 19-07-31 |
Chairman | 70 | 16-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 363 | +0.97% | 1,268,295 |
24-03-27 | 359.5 | -0.28% | 591,977 |
24-03-26 | 360.5 | +1.26% | 1,279,717 |
24-03-25 | 356 | -0.56% | 1,083,525 |
24-03-22 | 358 | -0.28% | 994,299 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.57% | 1.25B | |
+15.91% | 129B | |
+8.79% | 77.38B | |
+2.25% | 71.82B | |
+21.52% | 51.45B | |
+42.38% | 45.11B | |
+1.18% | 40.51B | |
+18.65% | 26.68B | |
+81.53% | 24.43B | |
+21.12% | 23.56B |